There is light at the end of the tunnel:
GSK - muscling in on cancer
GSK expects to have four key cancer drugs in final-stage clinical trials next year, it said on Wednesday. (trials in 2006)
Europe's biggest drug maker said the four drugs -- Tykerb, formerly known as lapatinib, eltrombopag, casopitant and pazopanib -- all held promise for fighting tumours or helping patients overcome the side-effects of chemotherapy.
Until now, oncology has been a small area for Glaxo but the group believes new products will make it a major player in the fast-growing world of cancer medicine.
I hope this gives you some comfort.
RN CCRN, Critical Care and Emergency Department Manager for 26 years.
Depression 25 years, Husband Crohns Disease 30 years
My Father and 5 siblings all died of Cancer. It is a subject close to my heart to help people with Cancer.
"If you doubt you can accomplish something, then you can’t accomplish it. You have to have confidence in your ability, and then be tough enough to follow through.”